-The Hindu The National Commission for Women on Saturday decided to intervene on behalf of the 23-year-old acid attack victim Preeti Rathi who was assaulted recently in Mumbai. Preeti, a qualified nurse, had gone to Mumbai to join as a medical staff at the INHS Asvini Hospital in Colaba and was attacked at the railway station. The victim's vision has suffered partial impairment and she has extensive burns on her face and...
More »SEARCH RESULT
Money-or-poison plea to Mamata
-The Telegraph West Bengal: An agent of the Saradha Group fell ill in Siliguri today after a three-hour demonstration while investors hit the streets with placards asking the chief minister to give them back their money or provide them with poison. Dinabandhu Pal, who had collected Rs 16 lakh for the Saradha Group, was admitted to Siliguri subdivisional hospital after he complained of palpitation in front of Siliguri police station. His wife...
More »Pickles, papads, junk food raise risk of hypertension: Experts -Malathy Iyer
-The Times of India MUMBAI: The urban Indian's diet, pickled with takeaways from fast-food joints and instant foods that are ready in a jiffy at the end of a long working day, could worsen the present epidemic of hypertension due to its high proportion of salt. In a city where every fourth adult is believed to have hypertension, experts said the focus should be on reducing salt intake in the daily...
More »YK Sapru, founder chairperson of Cancer Patients Aid Association (CPAA) interviewed by Sushmi Dey
-The Business Standard Interview with Founder chairman of Cancer Patients Aid Association Though the legal battle over Glivec's patentability may be over for now, Y K Sapru, the man spearheading the fight against Swiss multinational Novartis, isn't resting. Sapru, founder chairman of Cancer Patients Aid Association, or CPAA (which moved the Supreme Court to keep the prices of the cancer drug low), tells Sushmi Dey what the judgment means to cancer patients....
More »Novartis patent case: Glivec developer Brian Druker hails SC ruling- Chidanand Rajghatta
-The Economic Times WASHINGTON: Big Pharma found little support from the small guy on the street as the Indian Supreme Court's decision to reject patent claims of the drug maker Novartis for its celebrated cancer medicine Glivec reverberated across the world. The pharma lobby railed against the decision but the overwhelming sentiment, from physicians to politicians, from academia to media, particularly in a country groaning from the high cost of health care,...
More »